Eric Francois, MD, on Rectal Cancer: Findings From the ACCORD12 Trial (French Language Version)

2016 Gastrointestinal Cancers Symposium
Tweet this page

Eric Francois, MD, of the Centre Antoine-Lacassagne, discusses in French the 5-year follow-up results from this phase III study of neoadjuvant treatment in rectal cancer (Abstract 490).

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.